Cargando…
Geo-prioritization framework for COVID-19 vaccine allocation in India
Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324408/ https://www.ncbi.nlm.nih.gov/pubmed/34364717 http://dx.doi.org/10.1016/j.vaccine.2021.07.084 |
_version_ | 1783731390345379840 |
---|---|
author | Mahajan, Akshay Kaur, Jasmine Sidana, Chirag Shivam, Shashwat Singh, Harpreet |
author_facet | Mahajan, Akshay Kaur, Jasmine Sidana, Chirag Shivam, Shashwat Singh, Harpreet |
author_sort | Mahajan, Akshay |
collection | PubMed |
description | Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have started administering vaccines to priority population groups. India is gearing up its critical components of the vaccine delivery system to effectively deliver vaccines across the country and has prioritized certain population groups to whom the vaccine will be administered. Considering India’s ambitious target to vaccinate close to 300 million people in the first phase of the vaccination drive with limited initial supply (which will be ramped up gradually), it is critical for stakeholders at all the levels – national, state and district – to understand the estimated need for vaccines across geographies based on the vulnerable population and disease epidemiology with the objective of preventing maximum number of future infections from the disease. This paper aims to describe a comprehensive geo-prioritization framework based on existing prevalence of COVID-19, high-risk co-morbidities, and demographic analysis to identify states/districts that could be most in need of the COVID-19 vaccines. |
format | Online Article Text |
id | pubmed-8324408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83244082021-08-02 Geo-prioritization framework for COVID-19 vaccine allocation in India Mahajan, Akshay Kaur, Jasmine Sidana, Chirag Shivam, Shashwat Singh, Harpreet Vaccine Commentary Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have started administering vaccines to priority population groups. India is gearing up its critical components of the vaccine delivery system to effectively deliver vaccines across the country and has prioritized certain population groups to whom the vaccine will be administered. Considering India’s ambitious target to vaccinate close to 300 million people in the first phase of the vaccination drive with limited initial supply (which will be ramped up gradually), it is critical for stakeholders at all the levels – national, state and district – to understand the estimated need for vaccines across geographies based on the vulnerable population and disease epidemiology with the objective of preventing maximum number of future infections from the disease. This paper aims to describe a comprehensive geo-prioritization framework based on existing prevalence of COVID-19, high-risk co-morbidities, and demographic analysis to identify states/districts that could be most in need of the COVID-19 vaccines. Published by Elsevier Ltd. 2021-08-31 2021-07-31 /pmc/articles/PMC8324408/ /pubmed/34364717 http://dx.doi.org/10.1016/j.vaccine.2021.07.084 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Mahajan, Akshay Kaur, Jasmine Sidana, Chirag Shivam, Shashwat Singh, Harpreet Geo-prioritization framework for COVID-19 vaccine allocation in India |
title | Geo-prioritization framework for COVID-19 vaccine allocation in India |
title_full | Geo-prioritization framework for COVID-19 vaccine allocation in India |
title_fullStr | Geo-prioritization framework for COVID-19 vaccine allocation in India |
title_full_unstemmed | Geo-prioritization framework for COVID-19 vaccine allocation in India |
title_short | Geo-prioritization framework for COVID-19 vaccine allocation in India |
title_sort | geo-prioritization framework for covid-19 vaccine allocation in india |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324408/ https://www.ncbi.nlm.nih.gov/pubmed/34364717 http://dx.doi.org/10.1016/j.vaccine.2021.07.084 |
work_keys_str_mv | AT mahajanakshay geoprioritizationframeworkforcovid19vaccineallocationinindia AT kaurjasmine geoprioritizationframeworkforcovid19vaccineallocationinindia AT sidanachirag geoprioritizationframeworkforcovid19vaccineallocationinindia AT shivamshashwat geoprioritizationframeworkforcovid19vaccineallocationinindia AT singhharpreet geoprioritizationframeworkforcovid19vaccineallocationinindia |